PHA Pharmagest Interactive SA

EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT

EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT

Villers-lès-Nancy, 21 July 2022 – 6:00 p.m. (CET)

PRESS RELEASE

H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT

WITH THE BROKERAGE FIRM GILBERT DUPONT

Under the liquidity agreement administered by the brokerage firm, Gilbert Dupont, on behalf of , liquidity account holdings at 30 June 2021 were as follows:

- Number of shares: 2,779

- Cash balance: €149,326.28

For the 2022 first half, a summary of total transactions is provided below:

PURCHASES42,335 shares€3,403,363.601,728 transactions
SALES41,146 shares€3,273,914.361,861 transactions

For information, liquidity account holdings were reported as follows:

in the half-year report of 31 December 2021:

- Number of shares: 1,590

- Cash balance: €278,775.56

when the liquidity agreement was first implemented:

- Number of shares: 2,219

- Cash balance: 50 000,00 €.

This liquidity agreement is executed in accordance with decision No. 2018-01 of 2 July 2018 of the Autorité des Marchés Financiers (“AMF”) establishing accepted market practices in relation to liquidity agreements for shares.

About

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment A

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).

ISIN: FR0012882389 - Ticker Code: EQS

For all the latest news on Equasens Group go to

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Jean-Yves SAMSON

Tel. +33 (0)3 83 15 90 67 -

Media Relations:

FIN’EXTENSO - Isabelle APRILE

+33 (0)1 39 97 61 22 -   

APPENDIX

 PurchasesSales
 Number of transactionsNumber of sharesNumber of transactionsNumber of sharesNumber of transactionsNumber of shares
TOTAL1 72842.3353.403.363.601 86141.1463.273.914.36
03/01/20222565761229.711417016056.01
04/01/2022840637572.781429527465
05/01/2022074268093.490807368
06/01/20223454348572.385807166
07/01/2022824021265.012048343069.98
10/01/20222356449412.325504455
11/01/20227180154751831427135.69
12/01/20221733929185.292854146717.08
13/01/20222144838470.392338332982.2
14/01/20221847240243916814390.39
17/01/2022622519160.012448541533.51
18/01/20222557549049.63526022230.99
19/01/2022025121319.89028023927.51
20/01/20223897547.21528924742.1
21/01/2022064554372.98020016980
24/01/2022034928220.38000
25/01/20221431824841.711136528798.5
26/01/202215039251427021236.2
27/01/2022033626069.8062248480.98
28/01/20221431824877.112239531022
31/01/20220002633126513.99
01/02/2022000045536913.6
02/02/20221117714497.891422718655
03/02/20222768154773.112164.2
04/02/20222153842051.32813810856.1
07/02/202246551383066252656.87
08/02/20223255844022.81621116891.79
09/02/2022000075760908.6
10/02/20222950941146.49616613625.6
11/02/20222462449153.983057945792.47
14/02/2022044234067.590251920
15/02/2022817613393.645100678491.54
16/02/20223648738019.219997926.9
17/02/20221839629925.2116462
18/02/20222942831877.7717513120
21/02/20221831122369.33463309
22/02/20222036525308.111944831401.48
23/02/20221728720386.992141729847.82
24/02/20222752335820.113199569426.52
25/02/20227856045.53162345120.28
28/02/20221619114199.992765048590.3
01/03/20222245934390.12824018277.99
02/03/20222441330423.112665849088.38
03/03/20221746935310.592840630881.9
04/03/20223757342328.61525418947.51
07/03/20221531321460.52354538344.51
08/03/20222232523614.991845933913.08
09/03/20222957141879.62357142260.62
10/03/20221237827984.42253840046.3
11/03/2022816412215.612246735156.18
14/03/202224030602031023781.81
15/03/20223048536848.021251897.5
16/03/2022000039930910.21
17/03/20221845035379.322428422445.8
18/03/20221136228444.42132825898.58
21/03/20227150119451730023935.41
22/03/2022517213901.92630424651.3
23/03/20222262350980.531215312647.81
24/03/2022062350717.12021017144.11
25/03/20221131055.63254644995.59
28/03/20222478063846.982962351636.92
29/03/20220002850542480.2
30/03/20221230926160.311624620965.99
31/03/2022924320746.492132027495.1
01/04/2022935530986.992531827807.51
04/04/2022020518215.99024421809.5
05/04/202221515455331504500
06/04/20221341536370.521939534837.5
07/04/20222048042142.71935831504.11
08/04/20221550243717.021312110617.5
11/04/20221724020521.8516514147
12/04/2022026422512.2070260274
13/04/20228192165471317815371.4
14/04/20221224921471.592038533282.4
19/04/20222656548410.61000
20/04/20222332127093.41417614981.81
21/04/20221724020086.992121012.8
22/04/20222242534593.09000
25/04/20221538930741.191938430443.21
26/04/20222039530804.31000
27/04/20221532224580.11132224734.78
28/04/2022713110151.41333425987.71
29/04/20221743033207.0151118636
02/05/20221036627945.312864949838.59
03/05/20221177.23160547338.59
04/05/20221620115876.211121917548.1
05/05/2022835028066.011848739518.98
06/05/20222558746337.61329823747.11
09/05/20222442332844.811826820868.2
10/05/20221425119338.62543333527.8
11/05/20222141331833.591527221174.79
12/05/20222435426772.49000
13/05/20221175.22359645800.51
16/05/202215038801834026454.89
17/05/2022628522141.911854342571.53
18/05/20221624419252.412840532067.62
19/05/20221429623440.391442333699.39
20/05/2022617414038.811124519791.81
23/05/20226196158392126821746.51
24/05/20222251941922.23917314031.6
25/05/20224776175.56927423
26/05/20221418514882.61413110562.01
27/05/202251229843.22351041486.1
30/05/20221019116122.12426522352.19
31/05/20222869757794.823322716.8
01/06/2022619015448.011725120566.89
02/06/202258066021633727993.11
03/06/20221323219484.22134228828.62
06/06/20221837030991.391116113467.01
07/06/2022727022371.012754845824.2
08/06/20223276164124.61956047423.71
09/06/20222950842303.418917583.2
10/06/20223255745458000
13/06/20221632024731.392028722276.39
14/06/20221831823871.45987451.4
15/06/20221336926821.912759543828.3
16/06/20222344632633.698715325
17/06/202281168426.213273554261.89
20/06/2022000039729878.5
21/06/2022056843020.77023818261.6
22/06/2022038028387.48048336209.79
23/06/20222155741781.572255041388.99
24/06/20220002640831223.91
27/06/20224856687.52429423186.99
28/06/20226228181461829723806.01
29/06/20221340331694.023493859.5
30/06/20221645434398.991340630902

Attachment



EN
21/07/2022

Underlying

PHAPharmagest Interactive SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE
Free
PHA Pharmagest Inte...

Equasens: availability of AGM preparatory materials

Equasens: availability of AGM preparatory materials Villers-lès-Nancy, 6 June 2025 - 6:00 p.m. (CET) PRESS RELEASE ANNUAL ORDINARY GENERAL MEETING MEETING NOTICE ON-LINE AVAILABILITY OF MEETING MATERIALS WEBCAST LIVE EQUASENS hereby provides notice to shareholders of the Annual Ordinary General Meeting to be held on Wednesday, June 25, 2025 at 5.30 pm at the Company’s registered office located in Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud). The original French language version of the agenda and the resolutions submitted by the Board of Directors to the Or...

June 6, 2025 1 EN
 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS : modalités de mise à disposition des documents préparatoires...

EQUASENS : modalités de mise à disposition des documents préparatoires à l'AG Villers-lès-Nancy, le 6 juin 2025 – 18:00 (CET) COMMUNIQUE DE PRESSE ASSEMBLEE GENERALE ORDINAIRE ANNUELLE AVIS DE CONVOCATION MISE EN LIGNE DES DOCUMENTS PREPARATOIRES RETRANSMISSION EN DIRECT La société EQUASENS invite ses actionnaires à participer à l’Assemblée Générale Ordinaire Annuelle qui se réunira le mercredi 25 juin 2025, à 17 heures 30, au Siège Social à Villers-lès-Nancy (Technopôle de Nancy-Brabois - 5 Allée de Saint Cloud). L'avis de réunion préalable, comprenant notamment l'ordre du jour de...

June 6, 2025 1 EN
Arnaud Riverain
  • Arnaud Riverain
PHA Pharmagest Inte...

EQUASENS (EQS) - CA T1 - La reprise prend forme / Achat - Obj. 71,9 € ...

CA T1 de 57 M€ +6,9% (+5,9% à périmètre constant) / 56,5 M€ attendus ; Apport de Calimed 0,5 M€.

PHA PHARMAGEST INTERACTIVE SA
05/13/25 May 13, 2025 4 FR
 PRESS RELEASE
Free
PHA Pharmagest Inte...

Equasens: Q1 revenue at 31 March 2025

Equasens: Q1 revenue at 31 March 2025 Villers-lès-Nancy, 12 May 2025 - 6:00 PM (CET) PRESS RELEASE Q1 revenue at 31 March 2025: €57.0m+ 6.9% growth on a reported basis and + 5.9% like-for-like Q1 2025 REVENUE (€m)2024Reported basis2025Reported basisChange /Reported basisOf which external growthLike-for-like change(organic growth)Equasens Group 53.357.03.76.9%0.53.25.9%Q1 2025 revenue / Division (€m)2024Reported basis2025Reported basisChange /Reported basisOf which external growthLike-for-like change(organic growth)Pharmagest39.842.02.25.5% 2.25.5%Axigate Link7.88.30.45.5% 0.45.5%e-Connec...

May 12, 2025 1 EN
 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS : Chiffre d’affaires au 31 mars 2025

EQUASENS : Chiffre d’affaires au 31 mars 2025 Villers-lès-Nancy, le 12 mai 2025 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires au 31 mars 2025 à 57,0 M€+ 6,9% en croissance publiée et + 5,9% en croissance organique CA T1 2025 (M€)Publié 2024Publié 2025Variation/publiéDont Croissances externesVariation/périmètre comparable (croissance organique)Groupe Equasens 53,357,03,76,9%0,53,25,9%CA T1 2025 / Division (M€)Publié 2024Publié 2025Variation/publiéDont Croissances externesVariation/périmètre comparable (croissance organique)Pharmagest39,842,02,25,5% 2,25,5%Axigate Link7,88,30,45,5%...

May 12, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch